Considerations for Choice of Cranioplasty Material for Pediatric Patients

Megan E H Still1, Sonja Samant2, Abraham Alvarado3

  • 1Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Florida, Gainesville, Florida, USA, megan.still@ufl.edu.

Pediatric Neurosurgery
|December 8, 2022
PubMed

Insights

Pediatric cranioplasty using autologous bone or alloplastic materials shows good outcomes. Younger children, craniosynostosis diagnosis, and autologous bone increase revision risk.

Area of Science:

  • Pediatric neurosurgery
  • Craniofacial surgery
  • Biomaterials in medicine

Background:

  • Cranioplasty material and timing in pediatric patients remain subjects of debate.
  • Both autologous and alloplastic materials present distinct indications and complication risks.

Purpose of the Study:

  • To evaluate outcomes of cranioplasty in pediatric patients.
  • To identify factors influencing revision surgery and implant removal.

Main Methods:

  • Retrospective cohort study of pediatric patients undergoing cranioplasty between 1991 and 2021.
  • Inclusion of 149 cranioplasty implants for analysis.

Main Results:

  • Younger age (≤6 years), craniosynostosis diagnosis, autologous bone use, and shorter time to cranioplasty predicted revision surgery.
  • No studied factors significantly impacted implant removal rates during revision.

Conclusions:

  • Both autologous and alloplastic cranioplasty materials demonstrate favorable outcomes with low revision rates in pediatric patients.
  • Alloplastic implants may be advantageous in cases of infection-related craniectomy due to lower revision and removal rates.
  • Cranioplasty for craniosynostosis is associated with a higher risk of revision surgery, irrespective of the implant material.
Abstract

Related Concept Videos